BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 32649232)

  • 1. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
    Ramacciotti E; Macedo AS; Biagioni RB; Caffaro RA; Lopes RD; Guerra JC; Orsi FA; Marques MA; Tafur AJ; Caprini JA; Nicolaides A; Carter CA; Filho CC; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936350. PubMed ID: 32649232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
    Horowitz NA; Brenner B
    Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
    [No Abstract]   [Full Text] [Related]  

  • 3. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.
    Spyropoulos AC; Levy JH; Ageno W; Connors JM; Hunt BJ; Iba T; Levi M; Samama CM; Thachil J; Giannis D; Douketis JD;
    J Thromb Haemost; 2020 Aug; 18(8):1859-1865. PubMed ID: 32459046
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.
    Hashemi A; Madhavan MV; Bikdeli B
    Semin Thromb Hemost; 2020 Oct; 46(7):789-795. PubMed ID: 32820478
    [No Abstract]   [Full Text] [Related]  

  • 7. Venous thromboembolism and COVID-19.
    Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O
    Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune-Mediated Coagulopathy in COVID-19 Infection.
    Vadasz Z; Brenner B; Toubi E
    Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
    Ornelas-Ricardo D; Jaloma-Cruz AR
    Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
    Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
    Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 coagulopathy vs disseminated intravascular coagulation.
    Levi M
    Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
    Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
    Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.
    Godoy LC; Goligher EC; Lawler PR; Slutsky AS; Zarychanski R
    CMAJ; 2020 Oct; 192(40):E1156-E1161. PubMed ID: 32816822
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
    Zhai Z; Li C; Chen Y; Gerotziafas G; Zhang Z; Wan J; Liu P; Elalamy I; Wang C;
    Thromb Haemost; 2020 Jun; 120(6):937-948. PubMed ID: 32316065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
    Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
    J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part I.
    Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2020 Oct; 46(7):757-762. PubMed ID: 33080660
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.